Tony Nguyen

Tony Nguyen is a managing director at RTW Investments. He serves as an Analyst at RTW, where he leads the commercial analysis of biopharma and medical technology assets. He is also the founding member of the firm’s internal Valuation Committee. Tony’s focus on the commercial viability of new drugs and technologies is a critical component of RTW’s work. We are living in an age where diseases are being redefined based on their genetic causes, and it is of paramount importance to understand the changing opportunity set of addressable patients across diseases. Tony received a BS in Electrical Engineering from the National University of Singapore and an MBA from St. John’s University, both on a full academic scholarship. POST NAVIGATION